The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective, single-arm, phase 2 trial exploring the use of pamiparib combined with surufatinib as neoadjuvant therapy for advanced, unresectable ovarian cancer (PASSION).
 
Bairong Xia
No Relationships to Disclose
 
Wenju Peng
No Relationships to Disclose
 
Yao Chen
No Relationships to Disclose
 
Wulin Shan
No Relationships to Disclose
 
Wenjing Jiang
No Relationships to Disclose
 
Wei Xiong
No Relationships to Disclose